Treatment modalities for drug-induced gingival enlargement

J Dent Hyg. 2012 Fall;86(4):272-7. Epub 2012 Nov 7.

Abstract

This paper identifies 3 specific classifications of commonly prescribed medications that are known to cause gingival enlargement and describes surgical and non-surgical treatment therapies. Primary risks associated with drug-induced gingival enlargement, including increased dental decay and periodontal disease are also discussed. The precise bacterial etiology in gingival enlargement remains unclear, although sufficient evidence exists to support the role of good oral hygiene in decreasing the incidence and severity of gingival enlargement and improving overall gingival health. Etiology, treatment planning and coordination of care between physician, dentist or dental hygienist when indicated are important factors determining whether a surgical or non-surgical course of treatment should be considered.

MeSH terms

  • Anti-Infective Agents, Local / therapeutic use
  • Anticonvulsants / adverse effects
  • Calcium Channel Blockers / adverse effects
  • Chlorhexidine / therapeutic use
  • Dental Plaque / prevention & control
  • Gingival Overgrowth / chemically induced*
  • Gingival Overgrowth / surgery
  • Gingival Overgrowth / therapy
  • Gingivectomy / methods
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Laser Therapy
  • Mouthwashes / therapeutic use
  • Oral Hygiene
  • Patient Care Planning
  • Patient Care Team
  • Risk Factors
  • Surgical Flaps

Substances

  • Anti-Infective Agents, Local
  • Anticonvulsants
  • Calcium Channel Blockers
  • Immunosuppressive Agents
  • Mouthwashes
  • Chlorhexidine